OTTAWA, Sept.1, 2017 /CNW/ -
Issue
Health Canada is advising Canadians that Apotex Inc. is voluntarily recalling one lot (lot 6G07) of its Apo-Nitroglycerin sublingual (under the tongue) spray (0.4 mg/metered dose) as the spray pump may malfunction and not deliver the drug.
Nitroglycerin is a prescription drug used to relieve acute attacks of angina (chest pain). The pump is intended to deliver the drug by spraying it under the tongue. Patients experiencing angina who do not receive nitroglycerin could be at risk of suffering a heart attack.
Who is affected
Affected product
Product |
Strength |
DIN |
Size / Format |
Lot Number |
Expiry (MM/YYYY) |
Apo-Nitroglycerin, (nitroglycerin sublingual spray) |
0.4mg/metered dose |
02393433 |
200 metered doses in a bottle |
6G07 |
01/2019 |
What consumers should do
What Health Canada is doing
Health Canada is monitoring the recall and the company's implementation of any necessary corrective and preventative actions. If new safety information is identified, Health Canada will take appropriate action and inform Canadians.
Related Links
For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
Également disponible en français
SOURCE Health Canada
Media Enquiries: Health Canada, (613) 957-2983; Public Enquiries: (613) 957-2991, 1-866 225-0709
Share this article